Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
03/2003
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022308A2 Therapeutic insert and therapeutic method
03/20/2003WO2002087424A3 Treatment and diagnosis of macrophage mediated disease
03/20/2003WO2002004490A3 Lipid metabolism molecules
03/20/2003WO2001085219A3 Identification, diagnosis, and treatment of breast cancer
03/20/2003US20030055307 Devices for detection and therapy of atheromatous plaque
03/20/2003US20030055045 Novel compounds with analgesic effect
03/20/2003US20030053953 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region
03/20/2003US20030053949 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/19/2003EP1293214A2 LTB4 antagonists and radiopharmaceuticals for imaging infection and inflammation
03/19/2003EP1292675A2 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
03/19/2003EP1292612A2 Glycopeptide phosphonate derivatives
03/19/2003EP1292611A2 Glycopeptide carboxy-saccharide derivatives
03/19/2003EP1292338A2 Stabiliser for radiopharmaceuticals
03/19/2003EP1292280A2 Multiple stimulus reversible hydrogels
03/19/2003EP0952853B1 Conjugate comprising an active agent, a polypeptide and a polyether
03/19/2003EP0865609B1 Method of diagnosing and treating epithelioma
03/19/2003EP0772459B1 TECHNETIUM-99m LABELED IMAGING AGENTS
03/19/2003EP0682530B1 Gas mixtures useful as ultrasound contrast media
03/19/2003CN1404402A Radioactive therapeutic Liposomes
03/18/2003US6534488 32P or 33P-labelled bisphosphonates as radiotherapeutic radiopharmaceuticals. The 32P- or 33P-labelled bisphosphonates, which are chemically identical to the unlabelled agent, are expected to target the lesion site in
03/18/2003US6534040 Chlorin and bacteriochlorin-based aminophenyl DTPA and N2S2 conjugates for MR contrast media and radiopharmaceuticals
03/18/2003US6534038 Ternary ligand complexes useful as radiopharmaceuticals
03/18/2003US6534037 Non-steroidal compounds for steroid receptors and uses relating thereto
03/18/2003US6534035 Methods of inhibiting clot formation
03/13/2003WO2003020949A2 Targeted nucleic acid constructs and uses related thereto
03/13/2003WO2003020945A2 An enzymatic process for the synthesis of organo-fluorine compounds
03/13/2003WO2003020320A2 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/13/2003WO2003020212A2 Treatment for central nervous system disorders
03/13/2003WO2003020106A2 Composite staple for completing an anastomosis
03/13/2003WO2002066469A3 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
03/13/2003WO2002026822A3 Pumpcn compositions and uses thereof
03/13/2003WO2001097848A3 Vitronectin receptor antagonist pharmaceuticals
03/13/2003US20030049853 Quantitative analysis of the measurement of expired 13C-labeled carbon dioxide following the ingestion of a 13C-enriched glucose source
03/13/2003US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
03/13/2003US20030049262 Methods for identification, diagnosis, and treatment of breast cancer
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003US20030049202 Method of using gadolinium neutron capture to treat cancers
03/13/2003CA2459514A1 An enzymatic process for the synthesis of organo-fluorine compounds
03/13/2003CA2458799A1 Treatment for central nervous system disorders
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458682A1 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/12/2003EP1289571A2 Prochelators of radiometal labeled molecules
03/12/2003EP1289570A1 Liposomal encapsulation of chelated actinium-225 and uses thereof
03/12/2003EP1289565A2 Compounds for targeting endothelial cells
03/12/2003EP1289564A2 T cell receptor fusions and conjugates and methods of use thereof
03/12/2003EP1289414A2 Combined impedance imaging and mammography
03/12/2003EP1187848A4 Annexin derivatives with endogenous chelation sites
03/12/2003CN1402702A Beta 2-adrenergic receptor agonists
03/12/2003CN1401661A Radio-labeled compound for imaging of thrombus
03/12/2003CN1401629A Image forming agent, its precursor and preparing process thereof
03/11/2003US6531483 Treating psychostimulant abuse, inhibiting action of psychostimulant, inhibiting neurotransmitter re-uptake, treating Parkinson's Disease, treating depression
03/06/2003WO2003019142A2 Compositions and methods for detection and regulation of genes associated with ruptured atherosclerotic plaque
03/06/2003WO2003018070A1 Stilbene derivatives and their use for binding and imaging amyloid plaques
03/06/2003WO2003017818A2 Management of gastro-intestinal disorders
03/06/2003WO2002099422A3 Individualization of therapy with alzheimer's disease agents
03/06/2003WO2002096367A3 Targeted multivalent macromolecules
03/06/2003WO2002083171A3 Cancer treatment by using fap-alpha specific antibodies
03/06/2003WO2002083068A8 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
03/06/2003WO2002066516A3 Antibodies that bind both bcma and taci
03/06/2003WO2002059264A3 Specific human antibodies for selective cancer therapy
03/06/2003WO2001080880A8 Apoptotic agents
03/06/2003US20030045902 Composite staple for completing an anastomosis
03/06/2003US20030044993 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
03/06/2003US20030044419 Use of reagents derived from nucleic acid and amino acid sequences of Int6 gene in diagnostic methods, immunotherapy, gene therapy and as vaccines
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287016A2 Radioimaging probes and the use thereof
03/05/2003EP1286705A2 Bioconjugates of nanoparticles as radiopharmaceuticals
03/05/2003EP1286704A2 Ethylenedicysteine (ec)-drug conjugates
03/05/2003EP1286692A1 Intrathecal administration of rituximab for treatment of central nervous system lymphomas
03/05/2003EP0932417B1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system
03/05/2003EP0724457B1 Radiation sensitization using texaphyrins
03/05/2003EP0669913B1 Detection of hypoxia
03/05/2003CN1102411C Preparation for detecting urease activity in stomach
03/04/2003US6528627 Bridged aromatic substituted amine ligands with donor atoms
03/04/2003US6528263 Identifying a cell expressing protooncogene polypeptide by contacting a nucleic acid with a polynucleotide reagent and detecting its binding; can be used in diagnosis and treatment of cancer
03/04/2003US6528039 Low density microspheres and their use as contrast agents for computed tomography and in other applications
03/04/2003US6527693 Methods and implants for providing radiation to a patient
02/2003
02/27/2003WO2003016337A1 Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope
02/27/2003WO2003015870A2 Radioactive implantable devices and their production methods
02/27/2003WO2003015832A1 Diagnostic agent for pancreatic exocrine function
02/27/2003WO2003015818A1 Treating, preventing, or detecting angiogenesis with an anti-a2b antibody
02/27/2003WO2003015755A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
02/27/2003WO2003015606A2 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
02/27/2003WO2002085903A3 Amyloid plaque aggregation inhibitors and diagnostic imaging agents
02/27/2003WO2002056747A3 Radioactive medical devices for inhibiting a hyperplastic response
02/27/2003WO2002004030A3 Stable radiopharmaceutical compositions
02/27/2003WO2001098543A3 Method of diagnosing, monitoring, staging, imaging and treating breast cancer
02/27/2003WO2001097861A3 Vitronectin receptor antagonist pharmaceuticals
02/27/2003WO2001097860A3 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy
02/27/2003US20030039959 Detection of premature tumor cells in mammary gland tissue; obtain mammary gland tissue, incubate with diagnostic agent, monitor sample for binding and signal, presence of signal indicates premature cancer
02/27/2003US20030039683 Multilayer binding; lamellar surface structure
02/27/2003US20030039611 Selectively binds to antigen to cause cell impairment
02/27/2003CA2456966A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy
02/26/2003EP1285668A1 Preparations for evaluating eliminative ability of stomach
02/26/2003EP1284958A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
02/26/2003EP1284757A1 System comprising a carrier substrate and a ti/p or. ai/p coating
02/26/2003EP1284684A2 Radioactivable composition suitable for fabrication of implantable medical devices
02/26/2003EP1004321B1 Stable radioactive medecine
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 243